Medicare Enrolled

Dr. Didier Demesmin, M.D.

Interventional Pain Medicine Physician · Somerset, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
59 VERONICA AVE, Somerset, NJ 08873
7328736868
In practice since 2006 (20 years)
NPI: 1336170216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Demesmin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demesmin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Demesmin

Dr. Didier Demesmin is an interventional pain medicine physician in Somerset, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Demesmin performed 9,382 Medicare services across 773 unique beneficiaries.

Between the years covered by Open Payments, Dr. Demesmin received a total of $33,274 from 35 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Demesmin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in NJ $33,274 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,382
Medicare services
Top 5% in NJ for interventional pain medicine physician
773
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~469 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Triamcinolone acetonide injection, 1 mg
An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives.
8,105 $3 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
686 $79 $445
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
131 $0 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
85 $144 $1,036
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
51 $58 $2,159
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
50 $277 $17,375
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
45 $124 $11,367
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
42 $96 $586
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
41 $160 $9,561
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
40 $108 $1,758
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
34 $47 $2,917
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
22 $206 $11,932
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
21 $106 $10,524
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
15 $207 $10,500
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
14 $237 $7,700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$33,274
Total received (2018-2024)
Avg $4,753/year across 7 years
Top 5% in NJ for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,000 (60.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,274 (39.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,272
2023
$17,063
2022
$1,780
2021
$2,421
2020
$347
2019
$734
2018
$2,657

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Milestone Scientific Inc.
$5,000
PAINTEQ LLC
$1,142
Boston Scientific Corporation
$841
BIOTRONIK NRO, Inc.
$553
Abbott Laboratories
$249
Saluda Medical Americas, Inc.
$219
ETS Wound Care LLC
$135
SI-BONE, INC.
$53
Medtronic, Inc.
$52
Nevro Corp.
$15
Vertos Medical, Inc.
$13
Top 3 companies account for 84.4% of 2024 payments
All-time payments by company (2018-2024) ›
Milestone Scientific Inc.
$20,000
Boston Scientific Corporation
$3,492
PAINTEQ LLC
$2,636
Vertiflex, Inc.
$2,037
Nevro Corp.
$967
Abbott Laboratories
$625
BIOTRONIK NRO, Inc.
$553
Vertos Medical, Inc.
$435
Medtronic, Inc.
$377
Saluda Medical Americas, Inc.
$305
SCILEX PHARMACEUTICALS INC.
$216
Stimwave Technologies Incorporated
$200
Medtronic USA, Inc.
$155
SPR Therapeutics, Inc
$140
ETS Wound Care LLC
$135
Nuvectra Corporation
$133
Nalu Medical, Inc.
$126
TissueTech, Inc.
$113
BOSTON SCIENTIFIC CORPORATION
$88
FIDIA PHARMA USA INC.
$78
Electronic Waveform Lab, Inc.
$57
Flexion Therapeutics, Inc.
$56
SI-BONE, INC.
$53
Pacira Pharmaceuticals Incorporated
$52
Bioventus LLC
$43
Relievant Medsystems, Inc.
$33
Jazz Pharmaceuticals Inc.
$26
SI-BONE, Inc.
$24
Inspire Medical Systems, Inc.
$24
Avanos Medical
$23
DePuy Synthes Sales Inc.
$19
Collegium Pharmaceutical, Inc.
$15
PFIZER INC.
$14
Integrity Implants Inc.
$13
RedHill Biopharma Inc.
$13
Top 3 companies account for 78.5% of all-time payments
Associated products mentioned in payments ›
Algovita · COMPUFLO EPIDURAL · Durolane · ETERNA · Evoke · Evoke SCS · Exparel · FlareHawk · GELSYN 3 · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENVISC 850 SODIUM HYALURONATE · General - Pain Management · HYALGAN · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LYRICA · MIRRAGEN ADVANCED WOUND MATRIX · MYSTIM · Movantik · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · ORTHOVISC · Omnia · PAINTEQ · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Prokera · Prospera · SPECTRA WAVEWRITER · SPRINT PNS System · SUPERION · Senza · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Superion Indirect Decompression System · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for interventional pain medicine physician in NJ.

Looking for an interventional pain medicine physician in Somerset?
Compare interventional pain medicine physicians in the Somerset area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional pain medicine physicians within 10 mi
22
Per 100K population
6.4
County median income
$135,960
Nearest hospital
UNIVERSITY BEHAVIORAL HEALTH CARE
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Demesmin is a mixed practice specialist, with above-average Medicare volume (top 5% in NJ), with consulting-driven industry engagement in the top 5% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Demesmin experienced with triamcinolone acetonide injection, 1 mg?
Based on Medicare claims data, Dr. Demesmin performed 8,105 triamcinolone acetonide injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Demesmin receive payments from pharmaceutical companies?
Yes. Dr. Demesmin received a total of $33,274 from 35 companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demesmin's costs compare to other interventional pain medicine physicians in Somerset?
Dr. Demesmin's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demesmin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →